Imtiaz A Samjoo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Systematic Review

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

Current medical research and opinion

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Veronique Lambert, Sarah Kane, Belal Howidi, Nguyen Bao Ngoc, David Chandiwana, Yan Wu, Michelle Edwards, Imtiaz A Samjoo
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i. BMC cancer 24 (1) (2024)
Imtiaz A Samjoo, Alexandra Hall, Connie Chen, Nguyen Bao Ngoc, Meaghan Bartlett, Mary Lou Smith, Nadia Harbeck, Joseph Christopher Cappelleri, Meghan Karuturi, Doris Makari, Lillian Shahied Arruda, Rickard Sandin, Kent A Hanson, Justin Doan
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib. Journal of comparative effectiveness research (2024)
Veronique Lambert, Sarah Kane, Belal Howidi, Nguyen Bao Ngoc, David Chandiwana, Yan Wu, Michelle Edwards, Imtiaz A Samjoo
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i. BMC cancer 24 (1) (2024)
Imtiaz A Samjoo, Susan Lavinia Greco, Sarah Walsh, Santosh Tiwari, Róisín Brennan, Ibolya Boer, Dieter A Häring, Luisa Klotz, Nicholas Adlard, Judit Banhazi
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis. Journal of comparative effectiveness research (2023)
Luciano J Costa, Parameswaran Hari, Jesus G Berdeja, Valerio De Stefano, Francesca Gay, Becky Hooper, Meaghan Bartlett, Anja Haltner, Emily Rosta, Shaji K Kumar, Thomas Martin, Maria-Victoria Mateos-Manteca, Philippe Moreau, Saad Z Usmani, Yunsi Olyslager, Jordan M Schecter, Tito Roccia, Ashraf Garrett, Sam Lee, Tonia Nesheiwat, Lida Pacaud, Changwei Zhou, Imtiaz A Samjoo, Yi Lin, Joris Diels, Satish Valluri, Katja Weisel
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion 38 (10) (2022)
Tom Martin, Saad Z Usmani, Jordan M Schecter, Tito Roccia, Carolyn C Jackson, William Deraedt, Tzu-Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Meaghan Bartlett, Anja Haltner, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A Samjoo
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion (2022)
Tom Martin, Saad Z Usmani, Jordan M Schecter, Martin Vogel, Carolyn C Jackson, William Deraedt, Hong Tian, Tzu-Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Anja Haltner, Chris Cameron, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A Samjoo
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion 37 (10) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Paul Spin, Susan Lavinia Greco, Chris Cameron, Róisín Brennan, Frank Dahlke, Nicholas Adlard
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses. Current medical research and opinion 37 (11) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Letter in reply. Journal of comparative effectiveness research 10 (17) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Efficacy classification of modern therapies in multiple sclerosis. Journal of comparative effectiveness research 10 (6) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis. Journal of comparative effectiveness research 9 (18) (2020)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Chris Cameron, Richard Nicholas, Frank Dahlke, Nicholas Adlard
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis. Current medical research and opinion 36 (7) (2020)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Chris Cameron, Richard Nicholas, Nicolas Rouyrre, Frank Dahlke, Nicholas Adlard
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis. Current medical research and opinion 36 (7) (2020)